BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Medipattern™ Corporation Expands B-CAD-FOR-LIFE(TM) Program With Ocean Medical Imaging Center in New Jersey


12/14/2009 9:56:06 AM

TORONTO, ONTARIO--(Marketwire - December 14, 2009) - Attention: Business/Financial Editors

The Medipattern Corporation ("Medipattern") (TSX VENTURE: MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, has announced that it has partnered with Ocean Medical Imaging Center (OMIC), developed through a partnership with Lake Forest, Calif.-based InSight Health Services Holdings Corp. ("Insight Imaging") (OTCBB: ISGT), to provide the service of B-CAD® computer aided detection of breast ultrasound imaging under the B-CAD-FOR-LIFE™ program.

B-CAD automatically characterizes breast lesions using the American College of Radiology (ACR) Ultrasound Breast Imaging Reporting and Data System (BI-RADS®). B-CAD increases accuracy, saves time, and improves efficiency.

"Our sonographers learned to use B-CAD within a few hours and our physicians saw a significant improvement in their ability to more efficiently communicate diagnoses. B-CAD enables them to simply click on standardized language and then it guides them through the process, replacing handwritten notes with BI-RADS evidenced-based descriptors," said Karen Starr-Brady, Regional Director of Enterprise Operations for Insight Imaging.

OMIC is a comprehensive, freestanding diagnostic imaging center whose goal is to provide patients with superior diagnostic imaging services in a caring, safe and convenient environment. By doing this, OMIC has earned the trust and confidence of physicians throughout our community who now depend on OMIC to provide the diagnostic imaging needs of their patients.

"With the importance of early detection, we believe this technology represents a significant contribution to breast imaging," said Joseph Triolo, M.D., a board-certified radiologist at OMIC. "Mammography can detect cancerous lesions long before a lump is ever felt and then we use breast ultrasound imaging to characterize the lump. B-CAD helps us to detail more evidence concerning masses and suspicious calcifications, providing a higher quality of patient care."

"It's our patients who win with this new technology," said Starr-Brady. "When women come to OMIC for their ultrasounds, they know they aren't only getting experienced, board-certified radiologists, but also advanced technology that is enhancing our ability to more accurately detect breast cancer."

"New Jersey represents our first step in rolling out B-CAD-FOR-LIFE on a national basis in The United States. The program provides affordable access to the latest ultrasound CAD technology innovations leading the way through B-CAD. We first piloted the program in New York where it has been well received," added Jeff Collins, CEO of The Medipattern Corporation. "OMIC and Insight Imaging have been very supportive in organizing the additional information that this task required. We would like to thank Art Gelber president of Healthcare iQ for providing reimbursement guidance, and Amy Eriksen from Physicians Consultant Medical Sales for facilitating this transaction."

About Insight Imaging:

Insight Imaging, headquartered in Lake Forest, California, is a provider of retail and wholesale diagnostic imaging services. Insight Imaging serves a diverse portfolio of customers, including healthcare providers, such as hospitals and physicians, and payors, such as managed care organizations, Medicare, Medicaid and insurance companies, in over 30 states, including the following targeted regional markets: California, Arizona, New England, the Carolinas, Florida and the Mid-Atlantic states. For more information, please visit www.insighthealth.com.

About The Medipattern Corporation:

Medipattern® (TSX VENTURE: MKI) is a pioneer in the development of medical software solutions that help improve imaging workflow and productivity. Our first-to-market, award-winning B-CAD® advances breast ultrasound computer aided detection (CAD) by streamlining workflow and organizing information into a comprehensive patient record. Medipattern uses its Cadenza™ CAD Technology to power the digital conversion in medical communications. B-CAD automatically creates fully digital standardized worksheets and reports that make every practice more efficient, productive and ultimately more effective. For more information, please visit the Company's website at: www.medipattern.com.

B-CAD® and Medipattern® are registered marks and Cadenza™ and B-CAD-FOR-LIFE™ are trademarks of The Medipattern Corporation. BI-RADS is a registered trademark of the American College of Radiology.

Forward-looking statements

This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential", and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at www.sedar.com). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Contacts:
MEDIPATTERN CONTACT:
The Medipattern Corporation
Jeff Collins, CEO
(416) 744-0009 ext. 224
jcollins@medipattern.com

Spinnaker Capital Markets Inc.
Kevin O'Connor
(416) 962-3300 ext. 226
ko@spinnakercmi.com

INSIGHT CONTACT:
Longo Communications
Trace Longo
(949) 364-2821


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->